True statements about emphysema -a) Breathlessness is always thereb) Diffusion rate for carbon monoxide is reducedc) Restrictive pattern of lung diseased) Long-term bronchodilator therapy is not effective
**Question:** True statements about emphysema - a) Breathlessness is always there; b) Diffusion rate for carbon monoxide is reduced; c) Restrictive pattern of lung disease; d) Long-term bronchodilator therapy is not effective
**Core Concept:** Emphysema is a chronic lung disease characterized by the destruction of lung parenchyma, leading to air trapping, reduced lung elasticity, and impaired gas exchange. Long-term bronchodilator therapy is not effective for emphysema because these medications primarily target bronchoconstriction and do not address the underlying lung tissue damage.
**Core Concept:**
Emphysema primarily affects the alveoli, causing destruction of lung parenchyma and impairing gas exchange. Breathlessness is a common symptom of emphysema due to the reduced capacity of the lungs to expand and contract, which leads to increased work of breathing and shortness of breath.
The **Diffusion rate for carbon monoxide (CO) is reduced** in emphysema. Diffusion is a process of gases crossing the alveolar-capillary membrane, and this reduction indicates impaired gas exchange.
Emphysema exhibits a **restrictive pattern of lung disease**. This means that the lung volumes (total lung capacity and vital capacity) are reduced, while the residual volume remains normal or increased due to the loss of elastic recoil of the lungs.
**Core Concept:** Emphysema is characterized by hyperinflation and increased residual volume. Long-term bronchodilator therapy is ineffective in treating emphysema because these medications primarily target bronchoconstriction and do not address the underlying lung tissue damage.
**Why the Correct Answer is Right:** Long-term bronchodilator therapy is not effective in treating emphysema because:
1. Emphysema primarily involves the destruction of lung parenchyma and impaired gas exchange, which is not addressed by bronchodilators.
2. Bronchodilators are designed to relax and dilate the bronchioles, which improves airflow but does not address the structural lung damage caused by emphysema.
3. Emphysema is a chronic lung disease, and long-term treatment strategies need to focus on slowing down the disease progression and preventing exacerbations rather than solely addressing bronchoconstriction.
**Why Other Answers are Incorrect:**
1. Breathlessness is a common symptom of emphysema due to reduced lung elastic recoil and impaired gas exchange, but addressing breathlessness with bronchodilators would not reverse the underlying lung damage.
2. Emphysema exhibits a restrictive pattern of lung disease, characterized by reduced lung volumes and decreased lung elasticity. However, bronchodilator therapy targets bronchoconstriction and does not address the structural lung damage caused by emphysema.
3. Emphysema is a chronic lung disease, and long-term treatment strategies should focus on slowing the disease progression and preventing exacerbations rather than solely addressing bronchoconstriction.
**Clinical Pearls:**
1. Emphysema primarily affects the alveoli and alveolar walls,